We use cookies on this site to enhance your user experience. This site uses cookies as described in our Cookie Policy. To see what cookies we serve and set your own preferences, please check our cookie settings panel. Otherwise, if you agree to our use of cookies and legal notice, you can continue to use our site.

Shaping the Future of Bariatric Surgery. Together.

According to the WHO, worldwide obesity rates have nearly tripled since 1975, affecting over 650 million adults aged 18 and over.1 As we begin to better understand the significant impact of obesity on people and the health care systems, Ethicon remains committed to working with multiple stakeholders to improve the treatment of this significant disease.

Shaping the Future of Surgery

Delivering Meaningful Innovation

Unpredictable tissue type and thickness are common during bariatric revision surgeries. The ECHELON FLEX GST System controls tissue movement to transect as you intend, even on challenging tissue.2†

Over the last 20 years, Ethicon has significantly invested in the treatment of obesity and related diseases. Through a combination of enabling technologies, research, education and training, patient education, and policy initiatives, Ethicon is looking to shape the future of bariatric surgery.

Responding with a caring spirit

Care4Today is a Digital Care solution connecting the health care team and patients, ensuring a seamless flow of communication before and after bariatric & metabolic procedures, engaging and educating patients, reassuring and supporting them throughout the entire obesity treatment journey.

Over a Century of Meaningful Innovation

At Ethicon, weʼre focused on improving health outcomes for patients and helping solve the greatest health challenges… with only meaningful innovation. The kind that led to the creation of the first sutures, that helped revolutionize surgery with minimally invasive procedures, and that elevates standards of care around the world.

1887 — Sterile Sutures

1887 — Sterile Sutures

Johnson & Johnson’s mass production of sterile sutures and other products ushered in the widespread practice of modern antiseptic surgery that dramatically raised survival rates.

1960 — SURGICEL Original

1960 — SURGICEL Original

SURGICEL made history as the first oxidized regenerated cellulose hemostat introducing new options for clinicians to manage surgical bleeding.

Used by surgeons around the world today for general surgery use, Coated VICRYL (polyglactin 910) Suture balances the surgeon’s need for slide with knot security in achieving reliable approximation and closure.

First Laparoscopic Cholecystectomy and development of Minimally Invasive solutions

1993 — Ethicon Endo-Surgery

1993 — Ethicon Endo-Surgery

Founded in Ohio, Ethicon Endo-Surgery brought surgical technologies and solutions including staplers, energy devices and trocars.

1995 — Telesurgery

1995 — Telesurgery

Our pioneering live telesurgery, Dr. J. Barry McKernan performed a laparoscopic cholecystectomy at the American College of Surgeons’ annual meeting introduced clinicians to the possibilities of distance learning.

1998 — DERMABOND Topical Skin Adhesive

1998 — DERMABOND Topical Skin Adhesive

DERMABOND Topical Skin Adhesive paved the way for replacing sutures with a new generation of skin closure solutions.1

Committed to shaping the future of surgery in the fight against obesity and metabolic diseases and helping to elevate the standard of care through research and evidence, best-in-class education and training, innovative products and expanding patient access to care.

2003 — PLUS Sutures

2003 — PLUS Sutures

The first commercially available antibacterial suture, Coated VICRYL Plus Antibacterial (polyglactin 910) Suture broke new ground in addressing a known risk factor for surgical-site infections (SSI) by preventing bacterial colonization of the suture.

Verb Surgical, founded in 2015, is developing a digital surgery platform built with technology from Verily (formerly Google Life Sciences) and Ethicon Endo-Surgery, Inc. Verb’s platform will include robotics, visualization, advanced instrumentation, data analytics, and connectivity.

2016 — NEUWAVE Medical Acquisition

2016 — NEUWAVE Medical Acquisition

Ethicon acquires NeuWave Medical, Inc., a company that manufactures and markets minimally invasive soft-tissue microwave ablation systems. This acquisition is consistent with the strategy of advancing innovation and investing in areas of unmet medical needs such as surgical oncology.

2017 — MEGADYNE Acquisition

2017 — MEGADYNE Acquisition

The acquisition of Megadyne’s innovative portfolio of electrosurgical tools represents a major step forward in Ethicon’s goal to deliver the most comprehensive suite of intelligent energy solutions that enhance precision and efficiency in the operating room.

Introducing MEGA SOFT Universal Plus Patient Return Electrode

MEGA SOFT Universal Plus is the newest addition to the MEGA SOFT family. It is a lightweight pressure reduction pad3,4,5i for easy handling in the OR. MEGA SOFT Universal Plus was designed with more cushion to increase patient comfort,4ii to decrease pressure4ii and to be more durable4,6ii as compared to MEGA SOFT Universal.

We are proud to share that MEGA SOFT has been used in over 100 million procedures worldwide.7

Bariatric revision surgeries demand predictable performance. The Ethicon Bariatric Revision Surgical Solution offers a portfolio of products from a company you know and trust to provide precision, efficiency and hemostasis.

The program featured a world-renowned faculty of 22 experts from 16 different countries, who shared the latest science and innovation advancing surgery in the fight against obesity and metabolic diseases.